Identification and verification of four candidate biomarkers for early diagnosis of osteoarthritis by machine learning
View abstract on PubMed
Summary
This summary is machine-generated.This study identified a four-gene biomarker panel (B3GALNT1, GRB10, KLF9, SCRG1) for early osteoarthritis (OA) diagnosis. This discovery offers new pathways for understanding OA mechanisms and developing diagnostic tools.
Area Of Science
- Biomarker discovery
- Genomics
- Osteoarthritis research
Background
- Osteoarthritis (OA) is a prevalent chronic joint disease.
- Early diagnosis is crucial for effective management.
- Identifying reliable diagnostic biomarkers remains a challenge.
Purpose Of The Study
- To identify and validate novel diagnostic biomarkers for osteoarthritis.
- To assess the clinical significance of candidate biomarkers in patient samples.
- To develop a robust diagnostic model for early OA detection.
Main Methods
- Utilized three Gene Expression Omnibus (GEO) datasets for training and validation.
- Applied machine learning algorithms (Random Forest, LASSO, SVM-RFE) to screen differentially expressed genes (DEGs).
- Validated candidate biomarkers using quantitative real-time PCR on peripheral blood samples and chondrocytes.
Main Results
- Screened 251 DEGs, with B3GALNT1, SCRG1, and ZNF423 identified by all algorithms.
- A combined model including B3GALNT1, GRB10, KLF9, and SCRG1 achieved high AUC values (0.986 training, 1.000 validation, 0.836 test set).
- Individual biomarkers showed variable performance, but the combined model demonstrated strong diagnostic potential.
Conclusions
- A four-gene signature (B3GALNT1, GRB10, KLF9, SCRG1) was identified as a promising biomarker panel for early osteoarthritis diagnosis.
- This panel offers a potential non-invasive diagnostic approach.
- Findings provide new insights into OA pathogenesis and potential therapeutic targets.

